Stifel lowers Paychex stock price target to $137 on integration challenges

Paychex (PAYX) reported recent fiscal first-quarter results, with adjusted EPS of $1.22 surpassing forecasts and total revenue of $1.54 billion meeting expectations, alongside 3.5% organic revenue growth. Despite maintaining its FY26 revenue guidance and slightly raising its EPS outlook to 9-11%, analysts exhibit mixed sentiment, with Stifel cutting its price target to $137 (Hold) and other firms like Wolfe Research and BMO Capital also lowering targets due to concerns including Paycor's growth below target and macroeconomic uncertainty. The stock, trading near its 52-week low, holds a 32% premium to the S&P 500 EPS multiple, below recent trends, indicating potential for rerating if organic growth reaccelerates.

Analysis

Paychex (PAYX) presents a mixed financial picture following its fiscal first-quarter results. The company surpassed analyst EPS forecasts with an adjusted diluted EPS of $1.22 versus an expected $1.20 and met revenue expectations at $1.54 billion. Management expressed confidence by maintaining its fiscal 2026 revenue guidance and raising its EPS growth outlook to a 9-11% range, citing cost synergies. However, this optimism is contrasted by cautious sentiment from the analyst community. Stifel, Wolfe Research, and BMO Capital have all recently reduced their price targets, citing concerns over macroeconomic uncertainty and specific business challenges. Notably, the acquired Paycor (PYCR) business is growing at 8-9%, underperforming the company's double-digit fiscal 2026 target and signaling potential integration-related disruptions. This has led Stifel to model organic revenue growth below the company's own guidance. Despite strong gross margins of 72.83%, the stock is trading near its 52-week low, and its 32% valuation premium to the S&P 500 EPS multiple is significantly below recent historical trends, indicating the market is pricing in the current growth headwinds.

Key Decisions for Investors

• Investors should weigh the company's positive EPS beat and raised full-year guidance against the cautious sentiment reflected in multiple analyst price target cuts and downward earnings revisions.
• Closely monitor future organic revenue growth figures and any commentary on the Paycor integration, as re-acceleration toward the guided 4.5-5.5% range is the primary catalyst for a potential stock re-rating from its current level near a 52-week low.
• Given the stock's valuation premium to the S&P 500 is well below its recent historical trend, value-oriented investors might consider the current price a potential entry point, contingent on management's ability to navigate integration headwinds and macroeconomic uncertainty.